关于 "Aurora Kinase" 的结果31+ 个结果
筛选:Apoptosis×
- RIP2 kinase inhibitor 1CAS: 1423186-80-4
GSK2983559 active metabolite is an active metabolite of GSK2983559, also is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.
- RIP1 kinase inhibitor 1CAS: 2095515-38-9
RIP1 kinase inhibitor 1 (compound 22) 是一种高效的，口服有效的，可穿透大脑的 RIP1 激酶抑制剂 (pKi=9.04)。
- Casein Kinase inhibitor A51CAS: 2079068-74-7
Casein Kinase inhibitor A51 是一种有效且具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂。Casein Kinase inhibitor A51 可诱导白血病细胞凋亡 (apoptosis)，并具有有效的抗白血病活性。
Apoptosis - RIP2 Kinase Inhibitor 3CAS: 1398053-50-3
RIP2 Kinase Inhibitor 3 是一种高效、选择性的受体相互作用蛋白 -2 (RIP2) 激酶抑制剂，IC50 值为 1 nM。
- RIP2 kinase inhibitor 2CAS: 1581270-11-2
RIP2kinaseinhibitor2是一种受体相互作用蛋白-2(RIP2)激酶抑制剂，详细信息请参考专利WO/2014043437A1中的化合物example9。
- TrkB Agonist Prodrug R13CAS: 1609067-49-3
TrkB Agonist Prodrug R13（R13）是原肌球蛋白相关激酶B（TrkB）激活剂7,8-二羟基黄酮的前药形式。
- LY 294002 hydrochlorideCAS: 934389-88-5
Prototypical PI 3-kinase inhibitor; also inhibits other kinases
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC17828 | BI-847325 | 1207293-36-4 | Other Apoptosis | ||
A selective dual MEK/Aurora kinase inhibitor | |||||
| GC14566 | CCT137690 | 1095382-05-0 | Other Apoptosis | ||
An inhibitor of Aurora kinases and FLT3 | |||||
| GC15217 | Danusertib (PHA-739358) | 827318-97-8 | Autophagy | ||
A pan-Aurora kinase and Abl inhibitor | |||||
| GC12612 | JNJ-7706621 | 443797-96-4 | CDK | ||
A dual inhibitor of CDKs and Aurora kinases | |||||
| GC13332 | Aurora A Inhibitor I | 1158838-45-9 | Other Apoptosis | ||
A potent and selective inhibitor of Aurora A kinase | |||||
| GC32775 | RIP2 kinase inhibitor 1 | 1423186-80-4 | RIP kinase | ||
GSK2983559 active metabolite is an active metabolite of GSK2983559, also is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1. | |||||
| GC37533 | RIP1 kinase inhibitor 1 | 2095515-38-9 | RIP kinase | ||
RIP1 kinase inhibitor 1 (compound 22) 是一种高效的，口服有效的，可穿透大脑的 RIP1 激酶抑制剂 (pKi=9.04)。 | |||||
| GC62442 | Casein Kinase inhibitor A51 | 2079068-74-7 | Apoptosis | ||
Casein Kinase inhibitor A51 是一种有效且具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂。Casein Kinase inhibitor A51 可诱导白血病细胞凋亡 (apoptosis)，并具有有效的抗白血病活性。 | |||||
| GC65967 | RIP2 Kinase Inhibitor 3 | 1398053-50-3 | RIP kinase | ||
RIP2 Kinase Inhibitor 3 是一种高效、选择性的受体相互作用蛋白 -2 (RIP2) 激酶抑制剂，IC50 值为 1 nM。 | |||||
| GC32860 | RIP2 kinase inhibitor 2 | 1581270-11-2 | RIP kinase | ||
RIP2kinaseinhibitor2是一种受体相互作用蛋白-2(RIP2)激酶抑制剂，详细信息请参考专利WO/2014043437A1中的化合物example9。 | |||||
| GC50253 | PF 543 hydrochloride | 1706522-79-3 | LPL Receptor | ||
A potent inhibitor of SPHK1 | |||||
| GC43217 | CDK/CRK Inhibitor | 784211-09-2 | Signaling Pathways | ||
A CDK/CRK-specific kinase inhibitor | |||||
| GC91967 | LMTK3 Inhibitor C28 | 2764850-23-7 | Apoptosis | ||
LMTK3 Inhibitor C28是一种多激酶抑制剂。 | |||||
| GC49883 | DAPK Substrate Peptide (trifluoroacetate salt) | - | Apoptosis | ||
A DAPK1 peptide substrate | |||||
| GC91977 | TrkB Agonist Prodrug R13 | 1609067-49-3 | Behavioral Neuroscience | ||
TrkB Agonist Prodrug R13（R13）是原肌球蛋白相关激酶B（TrkB）激活剂7,8-二羟基黄酮的前药形式。 | |||||
| GC43176 | CAY10575 | 916985-21-2 | Transcription Factors | ||
An IKKβ and Plk1 inhibitor | |||||
| GC44880 | SD 1029 | 118372-34-2 | Hepatitis | ||
A JAK2 inhibitor | |||||
| GC13202 | D4476 | 301836-43-1 | Autophagy | ||
Inhibitor of CK1 and ALK5 | |||||
| GC10442 | MK-8745 | 885325-71-3 | Other Apoptosis | ||
An Aurora A kinase inhibitor | |||||
| GC14409 | ZM 447439 | 331771-20-1 | Other Apoptosis | ||
Selective inhibitor of Aurora B kinase | |||||
| GC50009 | LY 294002 hydrochloride | 934389-88-5 | Autophagy | ||
Prototypical PI 3-kinase inhibitor; also inhibits other kinases | |||||
| GC16499 | Sorafenib Tosylate | 475207-59-1 | Other Apoptosis | ||
A multi-kinase inhibitor | |||||
| GC10008 | GSK1070916 | 942918-07-2 | Other Apoptosis | ||
A potent inhibitor of Aurora B and C kinases | |||||
| GC17346 | KT 5823 | 126643-37-6 | Other Apoptosis | ||
Potent selective inhibitor of cGMP-dependent protein kinase (PKG) | |||||